Figure 1. CFMs inhibit NSCLC cell growth.

Noted cell lines were either treated with DMSO (Control), with various CFMs (A–C), Erlotinib (B), or Rociletinib (C) for indicated dose and time. Cell viability was determined by MTT assay. The data in the histograms represent means of three independent experiments; bars, S.E. α, β, γ, δ, p ≤ 0.05 relative to the respective DMSO-treated controls.